• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体酸性脂肪酶缺乏症(LAL-D)患儿的诊断与治疗管理。文献综述及自身经验。

Diagnostic and therapeutic management of children with lysosomal acid lipase deficiency (LAL-D). Review of the literature and own experience.

作者信息

Wierzbicka-Rucińska Aldona, Jańczyk Wojciech, Ługowska Agnieszka, Lebensztejn Dariusz, Socha Piotr

机构信息

Department of Biochemistry, Radioimmunology and Experimental Medicine, e-mail

Gastroenterology, Hepatology and Eating Disorders, Children's Health Memorial Institute, Warsaw, Poland.

出版信息

Dev Period Med. 2016;20(3):212-215.

PMID:27941191
Abstract

Lysosomal acid lipase deficiency may present at any age (in infants, children and adults). Its presenting features commonly include elevated serum transaminase activity levels, hypercholesterolemia, fatty liver, progressive liver fibrosis, and cirrhosis. Nonspecific clinical manifestations can lead to a delay in the diagnosis of both children and adults. The early development of fibrosis and cirrhosis suggests that the lysosomal accumulation of cholesterol esters and triglycerides in the liver is a potent inducer of fibrosis. Elevated levels of low-density lipoprotein-cholesterol or low levels of high-density lipoprotein-cholesterol with elevated transaminase activity should raise the suspicion of lysosomal acid lipase deficiency in the diagnostic workup. Still, some patients may not present with abnormal triglyceride and cholesterol concentrations. Early onset LAL-D has a different clinical presentation, with acute symptoms, including liver failure, and can be confused with many other metabolic conditions or with lymphohistiocytosis. The dried blood spot test enables rapid diagnosis and should be widely applied when the cause of liver disease remains unknown.

摘要

溶酶体酸性脂肪酶缺乏症可在任何年龄出现(婴儿、儿童和成人)。其临床表现通常包括血清转氨酶活性水平升高、高胆固醇血症、脂肪肝、进行性肝纤维化和肝硬化。非特异性临床表现可导致儿童和成人的诊断延迟。纤维化和肝硬化的早期发展表明,肝脏中胆固醇酯和甘油三酯的溶酶体积聚是纤维化的有力诱导因素。在诊断检查中,低密度脂蛋白胆固醇水平升高或高密度脂蛋白胆固醇水平降低且转氨酶活性升高应引起对溶酶体酸性脂肪酶缺乏症的怀疑。然而,一些患者可能没有甘油三酯和胆固醇浓度异常。早发型LAL-D有不同的临床表现,有急性症状,包括肝衰竭,可能与许多其他代谢疾病或淋巴细胞组织细胞增生症混淆。干血斑试验能够实现快速诊断,当肝病病因不明时应广泛应用。

相似文献

1
Diagnostic and therapeutic management of children with lysosomal acid lipase deficiency (LAL-D). Review of the literature and own experience.溶酶体酸性脂肪酶缺乏症(LAL-D)患儿的诊断与治疗管理。文献综述及自身经验。
Dev Period Med. 2016;20(3):212-215.
2
Lysosomal Acid Lipase Deficiency溶酶体酸性脂肪酶缺乏症
3
Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.溶酶体酸性脂肪酶缺乏症——一种被低估的血脂异常和肝功能障碍的病因。
Atherosclerosis. 2014 Jul;235(1):21-30. doi: 10.1016/j.atherosclerosis.2014.04.003. Epub 2014 Apr 15.
4
Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.溶酶体酸性脂肪酶缺乏症中心血管风险的管理
Am J Cardiovasc Drugs. 2017 Jun;17(3):217-231. doi: 10.1007/s40256-017-0216-5.
5
Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.儿童期起病溶酶体酸性脂肪酶缺乏症患者的分子和临床特征。回顾性研究、随访及两种新型 LIPA 致病性变异的检测。
Atherosclerosis. 2017 Oct;265:124-132. doi: 10.1016/j.atherosclerosis.2017.08.021. Epub 2017 Aug 26.
6
Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.溶酶体酸性脂肪酶缺乏症:沃尔曼病和胆固醇酯贮积病。
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(1):99-106.
7
Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.酸性脂肪酶选择性抑制剂的延长使用在沃曼病和胆固醇酯贮积症的诊断中的应用。
Gene. 2014 Apr 10;539(1):154-6. doi: 10.1016/j.gene.2014.02.003. Epub 2014 Feb 6.
8
Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review.溶酶体酸性脂肪酶缺乏症(LAL-D)的酶替代疗法:一项系统文献综述
Ther Adv Rare Dis. 2021 Jul 18;2:26330040211026928. doi: 10.1177/26330040211026928. eCollection 2021 Jan-Dec.
9
Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.溶酶体酸性脂肪酶缺乏症:沃尔曼病和胆固醇酯贮积病的诊断与治疗
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:125-32.
10
Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update.作为溶酶体酸性脂肪酶缺乏症(LAL-D)表现形式的肝脏疾病和血脂异常。临床与诊断方面,以及一种新疗法。最新进展。
Arch Argent Pediatr. 2017 Jun 1;115(3):287-293. doi: 10.5546/aap.2017.eng.287.

引用本文的文献

1
Lysosomal acid lipase deficiency in pediatric patients: a scoping review.儿童患者溶酶体酸性脂肪酶缺乏症:范围综述。
J Pediatr (Rio J). 2022 Jan-Feb;98(1):4-14. doi: 10.1016/j.jped.2021.03.003. Epub 2021 May 6.
2
Lysosomal Acid Lipase Deficiency, a Rare Pathology: The First Pediatric Patient Reported in Colombia.溶酶体酸性脂肪酶缺乏症,一种罕见病症:哥伦比亚首例儿科患者报告
Am J Case Rep. 2018 Jun 9;19:669-672. doi: 10.12659/AJCR.908808.
3
[Congenital disorders of lipoprotein metabolism].[先天性脂蛋白代谢紊乱]
Herz. 2017 Aug;42(5):449-458. doi: 10.1007/s00059-017-4578-x.